相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia
Zhihua Ran et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis
Anuraag Jena et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2021)
Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese
Chun-Yu Wei et al.
NPJ GENOMIC MEDICINE (2021)
Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms
Devaraj Ezhilarasan
TOXICOLOGY (2021)
Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury via mitochondrial or other mechanisms
Payal Rana et al.
ACTA PHARMACEUTICA SINICA B (2021)
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases
Cara L. Mack et al.
HEPATOLOGY (2020)
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
P. Joly et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
Mary Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2017)
Clinical and histologic features of Azathioprine-induced hepatotoxicity
Sith Siramolpiwat et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis
Yue-Ping Liu et al.
PLOS ONE (2015)
Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis
Yue-Ping Liu et al.
PLOS ONE (2015)
Nomenclature for alleles of the thiopurine methyltransferase gene
Malin L. Appell et al.
PHARMACOGENETICS AND GENOMICS (2013)
Efficacy and Safety of Nonbiologic Immunosuppressants in the Treatment of Nonrenal Systemic Lupus Erythematosus: A Systematic Review
Jose M. Pego-Reigosa et al.
ARTHRITIS CARE & RESEARCH (2013)
Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease
L. Chouchana et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Gene Polymorphisms Involved in Manifestation of Leucopenia, Digestive Intolerance, and Pancreatitis in Azathioprine-Treated Patients
Katerina Wroblova et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Azathioprine-associated severe myelosuppression: Indication of routine determination of thiopurine S-methyltransferase variant?
S. Ngo et al.
REVUE DE MEDECINE INTERNE (2011)
Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease
Xian-Wen Dong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease
A. Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism
U. Boonsrirat et al.
LUPUS (2008)
EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics
G. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan
Chien-Hua Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy
O. Palmieri et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease
J. W. Winter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Ethnic differences in pharmacogenetically relevant genes
R. M. Engen et al.
CURRENT DRUG TARGETS (2006)
Frequency of thiopurine S-methyltransferase alleles in different ethnic groups living in Spain
H Corominas et al.
MEDICINA CLINICA (2006)
Anti-inflammatory and immunosuppressive drugs and reproduction
Monika Ostensen et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease
G Bastida et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease:: impact of thiopurine S-methyltransferase polymorphism
M Schwab et al.
PHARMACOGENETICS (2002)
分享论文
